NO20043582L - En nukleinsyre som koder for en G-proteinkoblet reseptor og anvendelser av dem - Google Patents

En nukleinsyre som koder for en G-proteinkoblet reseptor og anvendelser av dem

Info

Publication number
NO20043582L
NO20043582L NO20043582A NO20043582A NO20043582L NO 20043582 L NO20043582 L NO 20043582L NO 20043582 A NO20043582 A NO 20043582A NO 20043582 A NO20043582 A NO 20043582A NO 20043582 L NO20043582 L NO 20043582L
Authority
NO
Norway
Prior art keywords
protein
applications
nucleic acid
acid encoding
coupled receptor
Prior art date
Application number
NO20043582A
Other languages
English (en)
Norwegian (no)
Inventor
Paul S Wright
Haifeng Eishingdrelo
Jidong Cai
Holly Dressler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0219574.1A external-priority patent/GB0219574D0/en
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20043582L publication Critical patent/NO20043582L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20043582A 2002-02-14 2004-08-27 En nukleinsyre som koder for en G-proteinkoblet reseptor og anvendelser av dem NO20043582L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35668602P 2002-02-14 2002-02-14
GBGB0219574.1A GB0219574D0 (en) 2002-02-14 2002-08-22 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
PCT/US2003/004350 WO2003068803A2 (en) 2002-02-14 2003-02-13 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof

Publications (1)

Publication Number Publication Date
NO20043582L true NO20043582L (no) 2004-08-27

Family

ID=27736226

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043582A NO20043582L (no) 2002-02-14 2004-08-27 En nukleinsyre som koder for en G-proteinkoblet reseptor og anvendelser av dem

Country Status (10)

Country Link
EP (1) EP1476460A4 (es)
JP (1) JP2005517398A (es)
CN (1) CN1642971A (es)
AU (1) AU2003213051A1 (es)
BR (1) BR0307707A (es)
CA (1) CA2476239A1 (es)
MX (1) MXPA04007006A (es)
NO (1) NO20043582L (es)
RU (1) RU2004127439A (es)
WO (1) WO2003068803A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715080C (en) * 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
KR101137019B1 (ko) * 2009-05-25 2012-05-24 한국생명공학연구원 신규한 ｇｐｃｒ 단백질 및 이의 용도
CN113588940B (zh) * 2021-07-30 2023-05-12 菲鹏生物股份有限公司 一种提高间接标记灵敏度的方法和试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
WO2001096567A1 (fr) * 2000-06-15 2001-12-20 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice couplee a la proteine g et adn de ce recepteur

Also Published As

Publication number Publication date
WO2003068803A3 (en) 2004-07-29
AU2003213051A1 (en) 2003-09-04
RU2004127439A (ru) 2005-04-10
EP1476460A2 (en) 2004-11-17
BR0307707A (pt) 2005-03-01
CN1642971A (zh) 2005-07-20
WO2003068803A2 (en) 2003-08-21
MXPA04007006A (es) 2004-10-11
JP2005517398A (ja) 2005-06-16
EP1476460A4 (en) 2005-12-07
CA2476239A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
DK1470107T3 (da) Fluor-substituerede cykloalkanoindoler og anvendelser heraf som prostaglandin D2-receptorantagonister
FR14C0032I2 (fr) Pyrazolopyridines a substitution carbamate
NO20052335D0 (no) Dispergerbare defracirox-tabletter
FI20031548A (fi) Järjestelmä, joka mahdollistaa vastaanottotarkastuksen raportoinnin
NO20042554L (no) Informasjonsmatesystem som anvender kodeinformasjon
NO20034387L (no) PD-1, en reseptor for B7-4 og anvendelser derav
DE50308372D1 (de) Bohrhammer
ATE544762T1 (de) Calcium rezeptor modulatoren
NO20043899L (no) Kjemiske forbindelser
FI20022261A (fi) Puskurointijärjestely
DE60331028D1 (de) Verriegelungsmechanismus
ATE484484T1 (de) Calciumhypochlorit enthaltende tabletten
AU2003291691A1 (en) Chemical encoding technology for combinatorial synthesis
NO20043718L (no) Tradkoplet telefonisystem
DE60309170D1 (de) Telemetriesystem
DK1694311T3 (da) Tyggelige bløde kapsler indeholdende ugelatineret stivelse
NO20044373L (no) Azetidinderivater som CCR-3-reseptorantagonister
NO20043582L (no) En nukleinsyre som koder for en G-proteinkoblet reseptor og anvendelser av dem
DE60329360D1 (de) Wheatstonebrücke
DK1648926T3 (da) Glut-1 som en receptor til htlv-kapper og anvendelser heraf
DE50313240D1 (de) Mikromechanisches bauelement
AU2003298751A8 (en) Data structures for context based rule application
DE50311673D1 (de) Bohrhammer
NO20043123L (no) En nukleinsyre som koder for en G-proteinkoplet reseptor og anvendelsen av den
NO20042386L (no) En nukleinsyre som koder for en G-proteinkoplet reseptor, og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application